The use of 5-aminolevulinic acid (ALA) in photodynamic therapy (PDT)
β Scribed by P. Charlesworth; T.G. Truscott
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 154 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1011-1344
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Photodynamic (PDT) therapy is a relatively new technique with unique properties that make it attractive for the local treatment of superficial epithelial disorders. The objective of this study was to investigate the clinical response of PDT with the photosensitizing agent 5-aminolevulinic acid (5-AL
## Background and Objective: The impact of photodynamic therapy (PDT) on the endometrium following topical application of 5-aminolevulinic acid (ALA) was studied in a rat model. Study Design/ Materials and Methods: Fluorescence microscopy revealed peak ALA to protoporphyrin IX (Pp IX) conversion 3
## Abstract Exogenous 5βaminolevulinic acid (ALA) is taken up directly by bacteria, yeasts, fungi, and some parasites, which then induces the accumulation of protoporphyrin IX (PPIX). Subsequent light irradiation of PPIX leads to the inactivation of these organisms via photodamage to their cellular
Photodynamic therapy (PDT) is a novel treatment modality that produces local tissue necrosis with laser light after prior administration of a photosensitizing agent. We performed a study of topically applied 5-aminolevulinic acid (5-ALA) in the photodynamic treatment of women with high-grade cervica
## Abstract ## Objective 5βAminolevulinic acid based photodynamic therapy (5βALAβPDT) has revealed promising results in the treatment of inflammatory joint diseases due to the sensitivity of inflamed synovial tissue. For 5βALAβPDT to be safe and beneficial for intraβarticular applications, resista